Skip to main content
. 2010 Feb;100(2):254–263. doi: 10.2105/AJPH.2008.156497

TABLE 4.

Details of the Expressive Writing Studies Reviewed

Authors Study Year Study Design No. of Participants Study Population Variables Measured Findings
Petrie et al.83 2004 Randomized controlled trial (emotional or control topics) 37 HIV patients CD4+ lymphocyte count and viral load Postintervention improvements CD4+ lymphocyte counts
Graham et al.84 2008 Randomized controlled trial (anger expression or writing about goals nonemotionally) 102 Chronic illness patients Letter writing on 2 occasions, coded for degree of expressed anger and meaning making Improvements in anger expression group in control over pain, depressed mood, and pain severity
Junghaenel et al.85 2008 Randomized controlled trial (emotional disclosure, neutral, or usual care) 92 Fibromyalgia patients Pain, well-being, fatigue Improvements in interpersonally distressed group in psychological well-being, pain, and fatigue.
Gillis et al.86 2006 Randomized controlled trial (4 days of writing at home and control) 72 Fibromyalgia patients At-home written emotional disclosure; mood effects and changes in health from baseline to 1 month and 3 months Immediate improvements in written disclosure group in negative mood; at 1 month, disclosure led to few health benefits; at 3 months, negative mood and social support effects disappeared, and written disclosure decreased poor sleep, health care use, and physical disability
Broderick et al.87 2005 Randomized controlled trial (trauma writing, control writing, usual care) 92 Fibromyalgia patients Quality of life, anxiety, depression, pain, fibromyalgia Trauma writing decreased pain, fatigue, and psychological well-being at 4 months; benefits were not maintained at 10 months